SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-20-008099
Filing Date
2020-03-31
Accepted
2020-03-30 18:10:12
Documents
5
Effectiveness Date
2020-03-31

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea120116-s8_artara.htm S-8 126834
2 OPINION OF COOLEY LLP ea120116ex5-1_artara.htm EX-5.1 10811
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea120116ex23-1_artara.htm EX-23.1 2195
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. ea120116ex23-2_artara.htm EX-23.2 1970
5 GRAPHIC ex5-1_001.jpg GRAPHIC 7791
  Complete submission text file 0001213900-20-008099.txt   153780
Mailing Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014
Business Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014 646-844-0337
ArTara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-237497 | Film No.: 20758818
SIC: 2836 Biological Products, (No Diagnostic Substances)